Skip to main content
Journal cover image

Management of biliary complications after heart transplantation.

Publication ,  Journal Article
Peterseim, DS; Pappas, TN; Meyers, CH; Shaeffer, GS; Meyers, WC; Van Trigt, P
Published in: J Heart Lung Transplant
1995

BACKGROUND: Immunosuppression increases the risk of biliary complications in heart transplant recipients. METHODS: Patients undergoing heart transplantation since 1986 who were at risk for cholelithiasis (n = 60) were retrospectively studied. RESULTS: Cholestatic jaundice developed in all patients after the operation because of biliary obstruction from cholelithiasis, cyclosporine toxicity, Imuran toxicity, or Gilbert's disease. The incidence of cholelithiasis or sludge was 42% (n = 25 of 60). Gallstones developed within 1.8 +/- 1.1 years in 17% of patients (n = 8 of 48) with a normal pretransplantation ultrasonogram. Biliary colic or gallstone pancreatitis developed 2 +/- 1.2 years after transplantation in 58% of patients (n = 7 of 12) with asymptomatic gallstones diagnosed before transplantation. The overall incidence of cholecystectomy or cholecystectomy with Roux-en-Y cystojejunostomy was 40% (n = 24). Both open cholecystectomy (n = 5) and laparoscopic cholecystectomy (n = 19) were performed without significant complications. Recovery is significantly more rapid (p < 0.05) after laparoscopic cholecystectomy versus open cholecystectomy (1 week versus 3 weeks). CONCLUSIONS: This analysis indicates that transplant candidates who have gallstones on pretransplantation evaluation or in whom gallstones develop after transplantation should undergo laparoscopic cholecystectomy at the earliest time in their posttransplantation course (i.e., 3 months) regardless of their symptomatic status. Removal of the diseased gallbladder not only simplifies the evaluation of cholestatic jaundice by eliminating the need for multiple ultrasonograms to exclude acute cholecystitis or choledocholithiasis but also safely minimizes the risk of the development of severe biliary complications.

Duke Scholars

Published In

J Heart Lung Transplant

ISSN

1053-2498

Publication Date

1995

Volume

14

Issue

4

Start / End Page

623 / 631

Location

United States

Related Subject Headings

  • Surgery
  • Risk Factors
  • Reoperation
  • Postoperative Complications
  • Middle Aged
  • Male
  • Jejunostomy
  • Infant
  • Immunosuppressive Agents
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peterseim, D. S., Pappas, T. N., Meyers, C. H., Shaeffer, G. S., Meyers, W. C., & Van Trigt, P. (1995). Management of biliary complications after heart transplantation. J Heart Lung Transplant, 14(4), 623–631.
Peterseim, D. S., T. N. Pappas, C. H. Meyers, G. S. Shaeffer, W. C. Meyers, and P. Van Trigt. “Management of biliary complications after heart transplantation.J Heart Lung Transplant 14, no. 4 (1995): 623–31.
Peterseim DS, Pappas TN, Meyers CH, Shaeffer GS, Meyers WC, Van Trigt P. Management of biliary complications after heart transplantation. J Heart Lung Transplant. 1995;14(4):623–31.
Peterseim, D. S., et al. “Management of biliary complications after heart transplantation.J Heart Lung Transplant, vol. 14, no. 4, 1995, pp. 623–31.
Peterseim DS, Pappas TN, Meyers CH, Shaeffer GS, Meyers WC, Van Trigt P. Management of biliary complications after heart transplantation. J Heart Lung Transplant. 1995;14(4):623–631.
Journal cover image

Published In

J Heart Lung Transplant

ISSN

1053-2498

Publication Date

1995

Volume

14

Issue

4

Start / End Page

623 / 631

Location

United States

Related Subject Headings

  • Surgery
  • Risk Factors
  • Reoperation
  • Postoperative Complications
  • Middle Aged
  • Male
  • Jejunostomy
  • Infant
  • Immunosuppressive Agents
  • Humans